Amphetamine Cocaine Interaction Study - 2

This study has been terminated.
(Original P.I. left the institution)
Sponsor:
Collaborators:
University of Texas
Information provided by (Responsible Party):
The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00000305
First received: September 20, 1999
Last updated: May 17, 2012
Last verified: May 2012

September 20, 1999
May 17, 2012
Not Provided
Not Provided
Not Provided
  • Craving
  • Drug use
  • Medication compliance
  • Retention
  • Addiction severity
  • Mood indicators
  • Psychiatric interview
Complete list of historical versions of study NCT00000305 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Amphetamine Cocaine Interaction Study - 2
Amphetamine Cocaine Interaction Study

The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.

Not Provided
Interventional
Phase 1
Primary Purpose: Treatment
Cocaine-Related Disorders
Drug: Dextroamphetamine
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
0
Not Provided
Not Provided

Please contact site for information.

Male
18 Years to 45 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000305
NIDA-09262-2, P50DA009262, P50-09262-2
Yes
The University of Texas Health Science Center, Houston
The University of Texas Health Science Center, Houston
  • National Institute on Drug Abuse (NIDA)
  • University of Texas
Principal Investigator: John Grabowski, Ph.D. University of Texas
The University of Texas Health Science Center, Houston
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP